Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
CorMedix Inc
19KACurrent price
10.6 EUR
0 EUR (0.00%)
Last closed
11.35 USD
Company
www.cormedix.com
ISIN
US21900C3088
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
703 855 552 USD
Yield for 12 month
+230.33 %
1Y
3Y
5Y
10Y
15Y
19KA
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey. Address: 300 Connell Drive, Berkeley Heights, NJ, United States, 07922
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
16.25 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
+65 408 USD
Current Quarter
+11 456 115 000 USD
Last Quarter
+806 119 USD
Current Year
-205 562 USD
Last Year
+61 674 USD
Current Quarter
+10 769 517 000 USD
Last Quarter
+296 280 USD
Key Figures 19KA
1 year
3 years
5 years
10 years
EBITDA
-50 766 364 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-37.69 %
PEG Ratio
–
Return On Equity TTM
-65.04 %
Wall Street Target Price
16.25 USD
Revenue TTM
12 262 234 USD
Book Value
1.01 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-47.3 %
Dividend Yield
–
Gross Profit TTM
61 674 USD
Earnings per share
-0.8 USD
Diluted Eps TTM
-0.8 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics 19KA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 19KA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:5
Payout Ratio
–
Last Split Date
26.03.2019
Dividend Date
26.03.2019
Stock Valuation 19KA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
44.6429
Enterprise Value Revenue
53.6919
Price Sales TTM
57.4003
Enterprise Value EBITDA
-3.4966
Price Book MRQ
11.9883
Financials 19KA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 19KA
For 52 weeks
2.57 USD
13.85 USD
50 Day MA
8.98 USD
Shares Short Prior Month
9 268 532
200 Day MA
5.62 USD
Short Ratio
7.99
Shares Short
7 860 576
Short Percent
13.59 %
BeatStart